Effects of mosapride, a 5-hydroxytryptamine 4 receptor agonist, on electrical activity of the small intestine and cecum in horses

Naoki Sasaki Department of Veterinary Surgery, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido, 080-8555, Japan.

Search for other papers by Naoki Sasaki in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Kouichi Okamura Department of Animal Science, Dainippon Pharmaceutical Co, Fushio, Osaka, 563-0011, Japan.

Search for other papers by Kouichi Okamura in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Haruo Yamada Department of Veterinary Surgery, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro, Hokkaido, 080-8555, Japan.

Search for other papers by Haruo Yamada in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective—To examine the effects of various doses of mosapride, a 5-hydroxytryptamine 4 receptor agonist, on motility of the small intestine and cecum in horses by use of electrical activity and to determine the dose that provides the optimal response.

Animals—6 healthy adult Thoroughbreds.

Procedure—Electrical activity of the small intestine and cecum was recorded before and after mosapride administration by use of an electrogastrograph. Mosapride (0.5, 1, 1.5, and 2 mg/kg) was dissolved in 200 mL of water and administered orally to horses through a nasogastric tube. Three hours after drug administration, mean amplitude of electrical activity calculated for a period of 30 minutes was expressed as the percentage of the mean amplitude of electrical activity for a period of 30 minutes before drug administration.

Results—Mosapride administered orally increased the percentage of the mean amplitude of electrical activity in the small intestine and cecum in a dosedependent manner. Mean ± SD values differed significantly for 1, 1.5, and 2 mg/kg (127.0 ± 12.5%, 137.7 ± 22.2%, and 151.1 ± 24.0%, respectively) in the small intestine and for 1.5 and 2 mg/kg (130.1 ± 34.5% and 151.6 ± 45.2%, respectively) in the cecum.

Conclusions and Clinical Relevance—Analysis of results of this study clearly documents that mosapride promotes motility in the small intestine and cecum of horses and that the optimal orally administered dosage is 1.5 to 2 mg/kg. Therefore, mosapride may be useful for treatment of horses with gastrointestinal tract dysfunction. (Am J Vet Res 2005;66:1321–1323)

Abstract

Objective—To examine the effects of various doses of mosapride, a 5-hydroxytryptamine 4 receptor agonist, on motility of the small intestine and cecum in horses by use of electrical activity and to determine the dose that provides the optimal response.

Animals—6 healthy adult Thoroughbreds.

Procedure—Electrical activity of the small intestine and cecum was recorded before and after mosapride administration by use of an electrogastrograph. Mosapride (0.5, 1, 1.5, and 2 mg/kg) was dissolved in 200 mL of water and administered orally to horses through a nasogastric tube. Three hours after drug administration, mean amplitude of electrical activity calculated for a period of 30 minutes was expressed as the percentage of the mean amplitude of electrical activity for a period of 30 minutes before drug administration.

Results—Mosapride administered orally increased the percentage of the mean amplitude of electrical activity in the small intestine and cecum in a dosedependent manner. Mean ± SD values differed significantly for 1, 1.5, and 2 mg/kg (127.0 ± 12.5%, 137.7 ± 22.2%, and 151.1 ± 24.0%, respectively) in the small intestine and for 1.5 and 2 mg/kg (130.1 ± 34.5% and 151.6 ± 45.2%, respectively) in the cecum.

Conclusions and Clinical Relevance—Analysis of results of this study clearly documents that mosapride promotes motility in the small intestine and cecum of horses and that the optimal orally administered dosage is 1.5 to 2 mg/kg. Therefore, mosapride may be useful for treatment of horses with gastrointestinal tract dysfunction. (Am J Vet Res 2005;66:1321–1323)

All Time Past Year Past 30 Days
Abstract Views 29 0 0
Full Text Views 667 591 193
PDF Downloads 114 75 3
Advertisement